CD86 +1057G/A polymorphism and susceptibility to Ewing's sarcoma: A case-control study

DNA and Cell Biology

Volumn 31, Issue 4, 2012, Pages 537-540

  Wang, Jian ^a   Zhou, Yujia ^b   Feng, Dapeng ^c   Yang, Haitao ^a   Li, Feng ^a   Cao, Qianlai ^a   Wang, An ^a   Xing, Fei ^a  

^a Shanghai Corps Hospital   (China)

^b UNIVERSITY OF TORONTO   (Canada)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN;

ADULT; ARTICLE; CANCER LOCALIZATION; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; EWING SARCOMA; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HOST SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD86; BONE NEOPLASMS; CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOGISTIC MODELS; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SARCOMA, EWING;

EID: 84859778810     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1370     Document Type: Article

References (23)

1. Bernstein, M., Heinrich, K., and Paulussen, M. (2005). Ewing sarcoma family of tumors: Ewing sarcoma of bone and soft tissue and the peripheral primitive neuroectodermal tumors. In Principles and Practice of Pediatric Oncology, 5th edition. P.A. Pizzo, and D.G. Poplack, eds. (Lippincott Williams and Wilkins, Philadelphia), pp. 1002-1032.
2. Carvajal, R., and Meyers, P. (2005). Ewing's sarcoma and primitive neuroectodermal family of tumors. Hematol Oncol Clin North Am 19, 501-525.
3. Contardi, E., Palmisano, G.L., Tazzari, P.L., Martelli, A.M., Falà , F., Fabbi, M., Kato, T., Lucarelli, E., Donati, D., Polito, L., Bolognesi, A., Ricci, F., Salvi, S., Gargaglione, V., Mantero, S., Alberghini, M., Ferrara, G.B., and Pistillo, M.P. (2005). CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction. Int J Cancer 117, 538-550.
4. Corydon, T.J., Haagerup, A., Jensen, T.G., Binderup, H.G., Petersen, M.S., Kaltoft, K., Vestbo, J., Kruse, T.A., and Børglum, A.D. (2007). A functional CD86 polymorphism associated with asthma and related allergic disorders. J Med Genet 44, 509-515.
5. Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., Aurias, A., and Thomas, G. (1992). Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359, 162-165.
6. Greenwald, R.J., Freeman, G.J., and Sharpe, A.H. (2005). The B7 family revisited. Annu Rev Immunol 23, 515-548.
7. Delneste, Y., Bosotti, R., Magistrelli, G., Bonnefoy, J.Y., and Gauchat, J.F. (2000). Detection of a polymorphism in exon 8 of the human CD86 gene. Immunogenetics 51, 762-763.
8. Jellis, C.L., Wang, S.S., Rennert, P., Borriello, F., Sharpe, A.H., Green, N.R., Green, N.R., and Gray, G.S. (1995). Genomic organization of the gene coding for the costimulatory human Blymphocyte antigen B7-2 (CD86). Immunogenetics 42, 85-89.
9. Karosas, A.O. (2010). Ewing's sarcoma. Am J Health Syst Pharm 67, 1599-1605.
10. Kretschmar, C.S. (1994). Ewing's sarcoma and the "peanut" tumors. N Engl J Med Editorial 331, 325-327.
11. Liu, Y., Liang, W.B., Gao, L.B., Pan, X.M., Chen, T.Y., Wang, Y.Y., Xue, H., Zhang, L.S., and Zhang, L. (2010). CTLA4 and CD86 gene polymorphisms and susceptibility to chronic obstructive pulmonary disease. Hum Immunol 71, 1141-1146.
12. Marin, L.A., Moya-Quiles, M.R., Miras, M., Muro, M., Minguela, A., Bermejo, J., Ramírez, P., Garcia-Alonso, A.M., Parrilla, P., and Alvarez-López, M.R. (2005). Evaluation of CD86 gene polymorphism at + 1057 position in liver transplant recipients. Transpl Immunol 15, 69-74.
13. Pan, X.M., Gao, L.B., Liang, W.B., Liu, Y., Zhu, Y., Tang, M., Li, Y.B., and Zhang, L. (2010) CD86 + 1057 G/A polymorphism and the risk of colorectal cancer. DNA Cell Biol 29, 381-386.
14. Salomon, B., and Bluestone, J.A. (2001). Complexities of CD28/ B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 19, 225-252.
15. Seliger, B., Marincola, F.M., Ferrone, S., and Abken, H. (2008). The complex role of B7 molecules in tumor immunology. Trends Mol Med 14, 550-559.
16. Slavik, J.M., Hutchcroft, J.E., and Bierer, B.E. (1992). CD80 and CD86 are not equivalent in their ability to induce the tyrosine phosphorylation of CD28. J Biol Chem 274, 3116-3124.
17. Stremmel, C., Greenfield, E.A., Howard, E., Freeman, G.J. and Kuchroo, V.K. (1999). B7-2 expressed on EL4 lymphoma suppresses antitumor immunity by an interleukin 4-dependent mechanism. J Exp Med 189, 919-930.
18. Tang, S., Guo, W., Guo, Y., Qu, H.Y., and Li, D.S. (2005). In vitro antitumor immune response induced by fusion of dendritic cells and Ewing's sarcoma cells. Zhonghua Wai Ke Za Zhi 43, 803-806.
19. Turc-Carel, C., Aurias, A., Mugneret, F., Lizard, S., Sidaner, I., Volk, C., Thiery, J.P., Olschwwang, S., Philip, I., Berger, M.P., Philip, T., Lenoir, G.M., and Mazabraud, A. (1988). Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). Cancer Genet Cytogenet 32, 229-238.
20. Ueda, Y., Levine, B.L., Huang, M.L., Freeman, G.J., Nadler, L.M., June, C.H., and Ward, S.G. (1995). Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion. Int Immunol 7, 957-966.
21. Wang, W., Song, H., Liu, J., Song, B., and Cao, X. (2011a). CD86 + 1057G/A polymorphism and susceptibility to osteosarcoma. DNA Cell Biol [Epub ahead of print]. DOI: 10.1089/dna2011.1069.
22. Wang, W., Wang, J., Song, H., Liu, J., Song, B., and Cao, X. (2011b). Cytotoxic T-Lymphocyte antigen-4 + 49G/A polymorphism is associated with increased risk of osteosarcoma. Genet Test Mol Biomarkers 15, 503-506.
23. Waterhouse, P., Penninger, J.M., Timms, E., Wakeham, A., Shahinian, A., Lee, K.P., Thompson, C.B., Griesser, H., and Mak, T.W. (1995). Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270, 985-988.